nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—Topoisomerase Inhibitors—Mitoxantrone—multiple sclerosis	0.582	1	CiPCiCtD
Doxorubicin—NOS2—Dexamethasone—multiple sclerosis	0.0388	0.153	CbGbCtD
Doxorubicin—XDH—Azathioprine—multiple sclerosis	0.0342	0.135	CbGbCtD
Doxorubicin—TOP2A—Mitoxantrone—multiple sclerosis	0.0229	0.0901	CbGbCtD
Doxorubicin—CYP1B1—Mitoxantrone—multiple sclerosis	0.0178	0.0703	CbGbCtD
Doxorubicin—ABCC10—Methotrexate—multiple sclerosis	0.0137	0.0539	CbGbCtD
Doxorubicin—ABCC1—Mitoxantrone—multiple sclerosis	0.0127	0.0499	CbGbCtD
Doxorubicin—ABCG2—Cladribine—multiple sclerosis	0.0116	0.0458	CbGbCtD
Doxorubicin—ABCB11—Dexamethasone—multiple sclerosis	0.00925	0.0364	CbGbCtD
Doxorubicin—CYP1B1—Dexamethasone—multiple sclerosis	0.00925	0.0364	CbGbCtD
Doxorubicin—ABCC3—Methotrexate—multiple sclerosis	0.0086	0.0339	CbGbCtD
Doxorubicin—ABCG2—Mitoxantrone—multiple sclerosis	0.00849	0.0334	CbGbCtD
Doxorubicin—CYP2D6—Fingolimod—multiple sclerosis	0.00613	0.0241	CbGbCtD
Doxorubicin—ABCC1—Methotrexate—multiple sclerosis	0.00528	0.0208	CbGbCtD
Doxorubicin—ABCC2—Dexamethasone—multiple sclerosis	0.00487	0.0192	CbGbCtD
Doxorubicin—ABCG2—Dexamethasone—multiple sclerosis	0.0044	0.0173	CbGbCtD
Doxorubicin—ABCB1—Methylprednisolone—multiple sclerosis	0.00419	0.0165	CbGbCtD
Doxorubicin—ABCC2—Methotrexate—multiple sclerosis	0.00391	0.0154	CbGbCtD
Doxorubicin—CYP3A4—Fingolimod—multiple sclerosis	0.0039	0.0154	CbGbCtD
Doxorubicin—ABCG2—Methotrexate—multiple sclerosis	0.00354	0.0139	CbGbCtD
Doxorubicin—CYP2B6—Dexamethasone—multiple sclerosis	0.00309	0.0122	CbGbCtD
Doxorubicin—ABCB1—Mitoxantrone—multiple sclerosis	0.00306	0.012	CbGbCtD
Doxorubicin—ABCB1—Betamethasone—multiple sclerosis	0.00273	0.0107	CbGbCtD
Doxorubicin—ABCB1—Prednisolone—multiple sclerosis	0.00269	0.0106	CbGbCtD
Doxorubicin—ABCB1—Prednisone—multiple sclerosis	0.00254	0.01	CbGbCtD
Doxorubicin—CYP3A4—Methylprednisolone—multiple sclerosis	0.00251	0.00989	CbGbCtD
Doxorubicin—CYP3A4—Triamcinolone—multiple sclerosis	0.0019	0.0075	CbGbCtD
Doxorubicin—CYP3A4—Mitoxantrone—multiple sclerosis	0.00183	0.00722	CbGbCtD
Doxorubicin—CYP3A4—Betamethasone—multiple sclerosis	0.00163	0.00643	CbGbCtD
Doxorubicin—CYP3A4—Prednisolone—multiple sclerosis	0.00161	0.00635	CbGbCtD
Doxorubicin—ABCB1—Dexamethasone—multiple sclerosis	0.00159	0.00625	CbGbCtD
Doxorubicin—CYP3A4—Prednisone—multiple sclerosis	0.00152	0.00599	CbGbCtD
Doxorubicin—CYP2D6—Dexamethasone—multiple sclerosis	0.00149	0.00588	CbGbCtD
Doxorubicin—ABCB1—Methotrexate—multiple sclerosis	0.00127	0.00502	CbGbCtD
Doxorubicin—NOS1—nerve—multiple sclerosis	0.00118	0.0355	CbGeAlD
Doxorubicin—CYP3A4—Dexamethasone—multiple sclerosis	0.00095	0.00374	CbGbCtD
Doxorubicin—AKR1A1—retina—multiple sclerosis	0.000645	0.0194	CbGeAlD
Doxorubicin—NOS1—brainstem—multiple sclerosis	0.000506	0.0152	CbGeAlD
Doxorubicin—NDUFS3—brainstem—multiple sclerosis	0.000497	0.015	CbGeAlD
Doxorubicin—NOS1—retina—multiple sclerosis	0.000489	0.0147	CbGeAlD
Doxorubicin—NDUFS2—retina—multiple sclerosis	0.000486	0.0146	CbGeAlD
Doxorubicin—ABCB8—nervous system—multiple sclerosis	0.000471	0.0142	CbGeAlD
Doxorubicin—AKR1A1—medulla oblongata—multiple sclerosis	0.000466	0.014	CbGeAlD
Doxorubicin—DHCR7—retina—multiple sclerosis	0.000456	0.0137	CbGeAlD
Doxorubicin—ABCB8—central nervous system—multiple sclerosis	0.000454	0.0137	CbGeAlD
Doxorubicin—CBR3—nervous system—multiple sclerosis	0.000454	0.0136	CbGeAlD
Doxorubicin—ABCC6—retina—multiple sclerosis	0.000444	0.0134	CbGeAlD
Doxorubicin—ABCB8—cerebellum—multiple sclerosis	0.000443	0.0133	CbGeAlD
Doxorubicin—CBR3—central nervous system—multiple sclerosis	0.000437	0.0131	CbGeAlD
Doxorubicin—CBR3—cerebellum—multiple sclerosis	0.000427	0.0128	CbGeAlD
Doxorubicin—AKR1A1—midbrain—multiple sclerosis	0.000426	0.0128	CbGeAlD
Doxorubicin—YWHAG—retina—multiple sclerosis	0.000418	0.0126	CbGeAlD
Doxorubicin—AKR1A1—spinal cord—multiple sclerosis	0.000416	0.0125	CbGeAlD
Doxorubicin—NDUFS7—midbrain—multiple sclerosis	0.000387	0.0117	CbGeAlD
Doxorubicin—NDUFS7—spinal cord—multiple sclerosis	0.000378	0.0114	CbGeAlD
Doxorubicin—RALBP1—retina—multiple sclerosis	0.000378	0.0114	CbGeAlD
Doxorubicin—ABCB8—brain—multiple sclerosis	0.00036	0.0108	CbGeAlD
Doxorubicin—NOS1—medulla oblongata—multiple sclerosis	0.000353	0.0106	CbGeAlD
Doxorubicin—NDUFS2—medulla oblongata—multiple sclerosis	0.000351	0.0106	CbGeAlD
Doxorubicin—AKR1A1—nervous system—multiple sclerosis	0.00035	0.0105	CbGeAlD
Doxorubicin—NDUFS3—medulla oblongata—multiple sclerosis	0.000347	0.0104	CbGeAlD
Doxorubicin—CBR3—brain—multiple sclerosis	0.000347	0.0104	CbGeAlD
Doxorubicin—AKR1A1—central nervous system—multiple sclerosis	0.000337	0.0101	CbGeAlD
Doxorubicin—AKR1A1—cerebellum—multiple sclerosis	0.00033	0.00992	CbGeAlD
Doxorubicin—DHCR7—medulla oblongata—multiple sclerosis	0.000329	0.00991	CbGeAlD
Doxorubicin—NDUFS2—midbrain—multiple sclerosis	0.000321	0.00965	CbGeAlD
Doxorubicin—NDUFS7—nervous system—multiple sclerosis	0.000318	0.00958	CbGeAlD
Doxorubicin—NDUFS3—midbrain—multiple sclerosis	0.000317	0.00954	CbGeAlD
Doxorubicin—NOS1—spinal cord—multiple sclerosis	0.000315	0.00948	CbGeAlD
Doxorubicin—NDUFS2—spinal cord—multiple sclerosis	0.000313	0.00942	CbGeAlD
Doxorubicin—NDUFS3—spinal cord—multiple sclerosis	0.000309	0.0093	CbGeAlD
Doxorubicin—NDUFS7—central nervous system—multiple sclerosis	0.000306	0.00922	CbGeAlD
Doxorubicin—YWHAG—medulla oblongata—multiple sclerosis	0.000302	0.0091	CbGeAlD
Doxorubicin—DHCR7—midbrain—multiple sclerosis	0.000301	0.00906	CbGeAlD
Doxorubicin—NDUFS7—cerebellum—multiple sclerosis	0.000299	0.00901	CbGeAlD
Doxorubicin—AURKA—nervous system—multiple sclerosis	0.000296	0.0089	CbGeAlD
Doxorubicin—DHCR7—spinal cord—multiple sclerosis	0.000294	0.00884	CbGeAlD
Doxorubicin—AURKA—central nervous system—multiple sclerosis	0.000285	0.00857	CbGeAlD
Doxorubicin—NQO1—retina—multiple sclerosis	0.000282	0.0085	CbGeAlD
Doxorubicin—YWHAG—midbrain—multiple sclerosis	0.000276	0.00831	CbGeAlD
Doxorubicin—RALBP1—medulla oblongata—multiple sclerosis	0.000273	0.00821	CbGeAlD
Doxorubicin—YWHAG—spinal cord—multiple sclerosis	0.00027	0.00811	CbGeAlD
Doxorubicin—AKR1A1—brain—multiple sclerosis	0.000268	0.00806	CbGeAlD
Doxorubicin—NOS1—nervous system—multiple sclerosis	0.000265	0.00799	CbGeAlD
Doxorubicin—NDUFS2—nervous system—multiple sclerosis	0.000264	0.00794	CbGeAlD
Doxorubicin—NDUFS3—nervous system—multiple sclerosis	0.00026	0.00784	CbGeAlD
Doxorubicin—NOS1—central nervous system—multiple sclerosis	0.000255	0.00769	CbGeAlD
Doxorubicin—CBR1—medulla oblongata—multiple sclerosis	0.000255	0.00767	CbGeAlD
Doxorubicin—NDUFS2—central nervous system—multiple sclerosis	0.000254	0.00764	CbGeAlD
Doxorubicin—AKR1C3—medulla oblongata—multiple sclerosis	0.000252	0.00757	CbGeAlD
Doxorubicin—NDUFS3—central nervous system—multiple sclerosis	0.000251	0.00755	CbGeAlD
Doxorubicin—NOS1—cerebellum—multiple sclerosis	0.00025	0.00752	CbGeAlD
Doxorubicin—RALBP1—midbrain—multiple sclerosis	0.000249	0.00751	CbGeAlD
Doxorubicin—NDUFS2—cerebellum—multiple sclerosis	0.000248	0.00747	CbGeAlD
Doxorubicin—DHCR7—nervous system—multiple sclerosis	0.000247	0.00745	CbGeAlD
Doxorubicin—NDUFS3—cerebellum—multiple sclerosis	0.000245	0.00738	CbGeAlD
Doxorubicin—RALBP1—spinal cord—multiple sclerosis	0.000243	0.00733	CbGeAlD
Doxorubicin—NDUFS7—brain—multiple sclerosis	0.000243	0.00732	CbGeAlD
Doxorubicin—DHCR7—central nervous system—multiple sclerosis	0.000238	0.00717	CbGeAlD
Doxorubicin—DHCR7—cerebellum—multiple sclerosis	0.000233	0.00701	CbGeAlD
Doxorubicin—CBR1—midbrain—multiple sclerosis	0.000233	0.00701	CbGeAlD
Doxorubicin—AKR1C3—midbrain—multiple sclerosis	0.00023	0.00692	CbGeAlD
Doxorubicin—POR—medulla oblongata—multiple sclerosis	0.00023	0.00692	CbGeAlD
Doxorubicin—CBR1—spinal cord—multiple sclerosis	0.000227	0.00684	CbGeAlD
Doxorubicin—YWHAG—nervous system—multiple sclerosis	0.000227	0.00683	CbGeAlD
Doxorubicin—AURKA—brain—multiple sclerosis	0.000226	0.00681	CbGeAlD
Doxorubicin—AKR1C3—spinal cord—multiple sclerosis	0.000224	0.00675	CbGeAlD
Doxorubicin—YWHAG—central nervous system—multiple sclerosis	0.000219	0.00658	CbGeAlD
Doxorubicin—YWHAG—cerebellum—multiple sclerosis	0.000214	0.00643	CbGeAlD
Doxorubicin—POR—midbrain—multiple sclerosis	0.00021	0.00632	CbGeAlD
Doxorubicin—RALBP1—nervous system—multiple sclerosis	0.000205	0.00617	CbGeAlD
Doxorubicin—POR—spinal cord—multiple sclerosis	0.000205	0.00617	CbGeAlD
Doxorubicin—NQO1—medulla oblongata—multiple sclerosis	0.000204	0.00614	CbGeAlD
Doxorubicin—NOS1—brain—multiple sclerosis	0.000203	0.0061	CbGeAlD
Doxorubicin—NOS3—nervous system—multiple sclerosis	0.000202	0.00607	CbGeAlD
Doxorubicin—NDUFS2—brain—multiple sclerosis	0.000202	0.00607	CbGeAlD
Doxorubicin—NDUFS3—brain—multiple sclerosis	0.000199	0.00599	CbGeAlD
Doxorubicin—RALBP1—central nervous system—multiple sclerosis	0.000197	0.00594	CbGeAlD
Doxorubicin—NOS3—central nervous system—multiple sclerosis	0.000194	0.00585	CbGeAlD
Doxorubicin—RALBP1—cerebellum—multiple sclerosis	0.000193	0.00581	CbGeAlD
Doxorubicin—CBR1—nervous system—multiple sclerosis	0.000191	0.00576	CbGeAlD
Doxorubicin—DHCR7—brain—multiple sclerosis	0.000189	0.00569	CbGeAlD
Doxorubicin—NQO1—midbrain—multiple sclerosis	0.000187	0.00562	CbGeAlD
Doxorubicin—CBR1—central nervous system—multiple sclerosis	0.000184	0.00555	CbGeAlD
Doxorubicin—ABCC10—medulla oblongata—multiple sclerosis	0.000182	0.00549	CbGeAlD
Doxorubicin—NQO1—spinal cord—multiple sclerosis	0.000182	0.00548	CbGeAlD
Doxorubicin—CBR1—cerebellum—multiple sclerosis	0.00018	0.00542	CbGeAlD
Doxorubicin—AKR1C3—cerebellum—multiple sclerosis	0.000178	0.00536	CbGeAlD
Doxorubicin—YWHAG—brain—multiple sclerosis	0.000174	0.00522	CbGeAlD
Doxorubicin—ABCC10—midbrain—multiple sclerosis	0.000167	0.00502	CbGeAlD
Doxorubicin—ABCC10—spinal cord—multiple sclerosis	0.000163	0.00489	CbGeAlD
Doxorubicin—POR—cerebellum—multiple sclerosis	0.000162	0.00489	CbGeAlD
Doxorubicin—RALBP1—brain—multiple sclerosis	0.000157	0.00472	CbGeAlD
Doxorubicin—NOS3—brain—multiple sclerosis	0.000154	0.00464	CbGeAlD
Doxorubicin—NQO1—nervous system—multiple sclerosis	0.000153	0.00462	CbGeAlD
Doxorubicin—NQO1—central nervous system—multiple sclerosis	0.000148	0.00444	CbGeAlD
Doxorubicin—CBR1—brain—multiple sclerosis	0.000146	0.0044	CbGeAlD
Doxorubicin—AKR1C3—brain—multiple sclerosis	0.000145	0.00435	CbGeAlD
Doxorubicin—NQO1—cerebellum—multiple sclerosis	0.000144	0.00434	CbGeAlD
Doxorubicin—ABCC3—nervous system—multiple sclerosis	0.000138	0.00414	CbGeAlD
Doxorubicin—ABCC3—central nervous system—multiple sclerosis	0.000133	0.00399	CbGeAlD
Doxorubicin—POR—brain—multiple sclerosis	0.000132	0.00397	CbGeAlD
Doxorubicin—ABCC10—cerebellum—multiple sclerosis	0.000129	0.00388	CbGeAlD
Doxorubicin—AURKA—Floxuridine—Cladribine—multiple sclerosis	0.000124	0.068	CbGdCrCtD
Doxorubicin—NQO1—brain—multiple sclerosis	0.000117	0.00353	CbGeAlD
Doxorubicin—CYP1B1—nervous system—multiple sclerosis	0.000108	0.00324	CbGeAlD
Doxorubicin—ABCG2—medulla oblongata—multiple sclerosis	0.000107	0.00321	CbGeAlD
Doxorubicin—ABCC3—brain—multiple sclerosis	0.000105	0.00317	CbGeAlD
Doxorubicin—CYP2D6—brainstem—multiple sclerosis	0.000105	0.00316	CbGeAlD
Doxorubicin—ABCC10—brain—multiple sclerosis	0.000105	0.00315	CbGeAlD
Doxorubicin—CYP1B1—central nervous system—multiple sclerosis	0.000104	0.00312	CbGeAlD
Doxorubicin—CYP1B1—cerebellum—multiple sclerosis	0.000101	0.00305	CbGeAlD
Doxorubicin—CBR3—Azacitidine—Cladribine—multiple sclerosis	0.000101	0.0551	CbGdCrCtD
Doxorubicin—ABCG2—midbrain—multiple sclerosis	9.76e-05	0.00294	CbGeAlD
Doxorubicin—ABCG2—spinal cord—multiple sclerosis	9.52e-05	0.00287	CbGeAlD
Doxorubicin—ABCC1—cerebellum—multiple sclerosis	9.12e-05	0.00274	CbGeAlD
Doxorubicin—AURKA—Clofarabine—Cladribine—multiple sclerosis	8.69e-05	0.0476	CbGdCrCtD
Doxorubicin—CYP1B1—brain—multiple sclerosis	8.23e-05	0.00248	CbGeAlD
Doxorubicin—CBR3—Fluorometholone—Methylprednisolone—multiple sclerosis	7.64e-05	0.0418	CbGdCrCtD
Doxorubicin—ABCG2—cerebellum—multiple sclerosis	7.55e-05	0.00227	CbGeAlD
Doxorubicin—CBR3—Fluorometholone—Betamethasone—multiple sclerosis	7.52e-05	0.0411	CbGdCrCtD
Doxorubicin—CBR3—Fluorometholone—Dexamethasone—multiple sclerosis	7.52e-05	0.0411	CbGdCrCtD
Doxorubicin—CBR1—Azacitidine—Cladribine—multiple sclerosis	7.46e-05	0.0408	CbGdCrCtD
Doxorubicin—ABCC1—brain—multiple sclerosis	7.41e-05	0.00223	CbGeAlD
Doxorubicin—CYP2B6—nervous system—multiple sclerosis	7.4e-05	0.00223	CbGeAlD
Doxorubicin—CBR3—Fluorometholone—Triamcinolone—multiple sclerosis	7.34e-05	0.0402	CbGdCrCtD
Doxorubicin—ABCB1—retina—multiple sclerosis	7.28e-05	0.00219	CbGeAlD
Doxorubicin—CYP2B6—central nervous system—multiple sclerosis	7.12e-05	0.00214	CbGeAlD
Doxorubicin—CBR3—Fluorometholone—Prednisone—multiple sclerosis	6.97e-05	0.0382	CbGdCrCtD
Doxorubicin—CBR3—Fluorometholone—Prednisolone—multiple sclerosis	6.8e-05	0.0372	CbGdCrCtD
Doxorubicin—CBR3—Triamcinolone—Methylprednisolone—multiple sclerosis	6.31e-05	0.0345	CbGdCrCtD
Doxorubicin—CBR3—Triamcinolone—Dexamethasone—multiple sclerosis	6.21e-05	0.034	CbGdCrCtD
Doxorubicin—CBR3—Triamcinolone—Betamethasone—multiple sclerosis	6.21e-05	0.034	CbGdCrCtD
Doxorubicin—ABCG2—brain—multiple sclerosis	6.13e-05	0.00185	CbGeAlD
Doxorubicin—CBR3—Fluocinolone Acetonide—Methylprednisolone—multiple sclerosis	5.8e-05	0.0317	CbGdCrCtD
Doxorubicin—CBR3—Triamcinolone—Prednisone—multiple sclerosis	5.76e-05	0.0315	CbGdCrCtD
Doxorubicin—CBR3—Fluocinolone Acetonide—Dexamethasone—multiple sclerosis	5.71e-05	0.0312	CbGdCrCtD
Doxorubicin—CBR3—Fluocinolone Acetonide—Betamethasone—multiple sclerosis	5.71e-05	0.0312	CbGdCrCtD
Doxorubicin—CYP2B6—brain—multiple sclerosis	5.66e-05	0.0017	CbGeAlD
Doxorubicin—CBR3—Triamcinolone—Prednisolone—multiple sclerosis	5.62e-05	0.0308	CbGdCrCtD
Doxorubicin—CYP3A4—nervous system—multiple sclerosis	5.59e-05	0.00168	CbGeAlD
Doxorubicin—CBR3—Fluocinolone Acetonide—Triamcinolone—multiple sclerosis	5.58e-05	0.0305	CbGdCrCtD
Doxorubicin—CYP2D6—nervous system—multiple sclerosis	5.5e-05	0.00166	CbGeAlD
Doxorubicin—CYP3A4—central nervous system—multiple sclerosis	5.38e-05	0.00162	CbGeAlD
Doxorubicin—CYP2D6—central nervous system—multiple sclerosis	5.29e-05	0.00159	CbGeAlD
Doxorubicin—ABCB1—medulla oblongata—multiple sclerosis	5.26e-05	0.00158	CbGeAlD
Doxorubicin—CYP2D6—cerebellum—multiple sclerosis	5.17e-05	0.00156	CbGeAlD
Doxorubicin—CBR3—Fluocinolone Acetonide—Prednisolone—multiple sclerosis	5.17e-05	0.0283	CbGdCrCtD
Doxorubicin—ABCB1—midbrain—multiple sclerosis	4.81e-05	0.00145	CbGeAlD
Doxorubicin—TOP2A—Floxuridine—Cladribine—multiple sclerosis	4.74e-05	0.026	CbGdCrCtD
Doxorubicin—ABCB1—spinal cord—multiple sclerosis	4.69e-05	0.00141	CbGeAlD
Doxorubicin—CYP2D6—brain—multiple sclerosis	4.2e-05	0.00127	CbGeAlD
Doxorubicin—ABCB1—nervous system—multiple sclerosis	3.96e-05	0.00119	CbGeAlD
Doxorubicin—ABCB1—central nervous system—multiple sclerosis	3.81e-05	0.00115	CbGeAlD
Doxorubicin—ABCB1—cerebellum—multiple sclerosis	3.72e-05	0.00112	CbGeAlD
Doxorubicin—TOP2A—Clofarabine—Cladribine—multiple sclerosis	3.32e-05	0.0182	CbGdCrCtD
Doxorubicin—CBR3—Betamethasone—Methylprednisolone—multiple sclerosis	3.12e-05	0.0171	CbGdCrCtD
Doxorubicin—CBR3—Dexamethasone—Methylprednisolone—multiple sclerosis	3.12e-05	0.0171	CbGdCrCtD
Doxorubicin—CBR3—Dexamethasone—Betamethasone—multiple sclerosis	3.07e-05	0.0168	CbGdCrCtD
Doxorubicin—CBR3—Betamethasone—Dexamethasone—multiple sclerosis	3.07e-05	0.0168	CbGdCrCtD
Doxorubicin—ABCB1—brain—multiple sclerosis	3.02e-05	0.00091	CbGeAlD
Doxorubicin—CBR3—Betamethasone—Triamcinolone—multiple sclerosis	3e-05	0.0164	CbGdCrCtD
Doxorubicin—CBR3—Dexamethasone—Triamcinolone—multiple sclerosis	3e-05	0.0164	CbGdCrCtD
Doxorubicin—CBR3—Dexamethasone—Prednisone—multiple sclerosis	2.85e-05	0.0156	CbGdCrCtD
Doxorubicin—CBR3—Betamethasone—Prednisone—multiple sclerosis	2.85e-05	0.0156	CbGdCrCtD
Doxorubicin—CBR3—Dexamethasone—Prednisolone—multiple sclerosis	2.78e-05	0.0152	CbGdCrCtD
Doxorubicin—CBR3—Betamethasone—Prednisolone—multiple sclerosis	2.78e-05	0.0152	CbGdCrCtD
Doxorubicin—Tachycardia—Methylprednisolone—multiple sclerosis	2.38e-05	0.000283	CcSEcCtD
Doxorubicin—Skin disorder—Methylprednisolone—multiple sclerosis	2.36e-05	0.000282	CcSEcCtD
Doxorubicin—Malnutrition—Prednisone—multiple sclerosis	2.36e-05	0.000281	CcSEcCtD
Doxorubicin—Erythema—Prednisone—multiple sclerosis	2.36e-05	0.000281	CcSEcCtD
Doxorubicin—Hyperhidrosis—Triamcinolone—multiple sclerosis	2.36e-05	0.000281	CcSEcCtD
Doxorubicin—Agranulocytosis—Methotrexate—multiple sclerosis	2.36e-05	0.000281	CcSEcCtD
Doxorubicin—Hyperhidrosis—Methylprednisolone—multiple sclerosis	2.35e-05	0.00028	CcSEcCtD
Doxorubicin—Convulsion—Betamethasone—multiple sclerosis	2.35e-05	0.00028	CcSEcCtD
Doxorubicin—Convulsion—Dexamethasone—multiple sclerosis	2.35e-05	0.00028	CcSEcCtD
Doxorubicin—Hypertension—Betamethasone—multiple sclerosis	2.34e-05	0.000279	CcSEcCtD
Doxorubicin—Hypertension—Dexamethasone—multiple sclerosis	2.34e-05	0.000279	CcSEcCtD
Doxorubicin—Asthenia—Mitoxantrone—multiple sclerosis	2.32e-05	0.000276	CcSEcCtD
Doxorubicin—Myalgia—Dexamethasone—multiple sclerosis	2.31e-05	0.000275	CcSEcCtD
Doxorubicin—Myalgia—Betamethasone—multiple sclerosis	2.31e-05	0.000275	CcSEcCtD
Doxorubicin—Anxiety—Dexamethasone—multiple sclerosis	2.3e-05	0.000274	CcSEcCtD
Doxorubicin—Anxiety—Betamethasone—multiple sclerosis	2.3e-05	0.000274	CcSEcCtD
Doxorubicin—Discomfort—Dexamethasone—multiple sclerosis	2.28e-05	0.000272	CcSEcCtD
Doxorubicin—Discomfort—Betamethasone—multiple sclerosis	2.28e-05	0.000272	CcSEcCtD
Doxorubicin—Haemoglobin—Methotrexate—multiple sclerosis	2.28e-05	0.000272	CcSEcCtD
Doxorubicin—Hypotension—Methylprednisolone—multiple sclerosis	2.27e-05	0.000271	CcSEcCtD
Doxorubicin—Pain—Prednisolone—multiple sclerosis	2.27e-05	0.00027	CcSEcCtD
Doxorubicin—Haemorrhage—Methotrexate—multiple sclerosis	2.27e-05	0.00027	CcSEcCtD
Doxorubicin—Hepatitis—Methotrexate—multiple sclerosis	2.27e-05	0.00027	CcSEcCtD
Doxorubicin—Pharyngitis—Methotrexate—multiple sclerosis	2.25e-05	0.000268	CcSEcCtD
Doxorubicin—Urinary tract disorder—Methotrexate—multiple sclerosis	2.24e-05	0.000267	CcSEcCtD
Doxorubicin—Vision blurred—Prednisone—multiple sclerosis	2.23e-05	0.000265	CcSEcCtD
Doxorubicin—Urethral disorder—Methotrexate—multiple sclerosis	2.22e-05	0.000265	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	2.22e-05	0.000265	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	2.22e-05	0.000264	CcSEcCtD
Doxorubicin—Anaphylactic shock—Dexamethasone—multiple sclerosis	2.21e-05	0.000264	CcSEcCtD
Doxorubicin—Anaphylactic shock—Betamethasone—multiple sclerosis	2.21e-05	0.000264	CcSEcCtD
Doxorubicin—Oedema—Dexamethasone—multiple sclerosis	2.21e-05	0.000264	CcSEcCtD
Doxorubicin—Oedema—Betamethasone—multiple sclerosis	2.21e-05	0.000264	CcSEcCtD
Doxorubicin—Diarrhoea—Mitoxantrone—multiple sclerosis	2.21e-05	0.000264	CcSEcCtD
Doxorubicin—Insomnia—Triamcinolone—multiple sclerosis	2.21e-05	0.000263	CcSEcCtD
Doxorubicin—Insomnia—Methylprednisolone—multiple sclerosis	2.2e-05	0.000262	CcSEcCtD
Doxorubicin—Infection—Betamethasone—multiple sclerosis	2.2e-05	0.000262	CcSEcCtD
Doxorubicin—Infection—Dexamethasone—multiple sclerosis	2.2e-05	0.000262	CcSEcCtD
Doxorubicin—Ill-defined disorder—Prednisone—multiple sclerosis	2.19e-05	0.000261	CcSEcCtD
Doxorubicin—Paraesthesia—Triamcinolone—multiple sclerosis	2.19e-05	0.000261	CcSEcCtD
Doxorubicin—Feeling abnormal—Prednisolone—multiple sclerosis	2.19e-05	0.000261	CcSEcCtD
Doxorubicin—Paraesthesia—Methylprednisolone—multiple sclerosis	2.19e-05	0.00026	CcSEcCtD
Doxorubicin—Visual impairment—Methotrexate—multiple sclerosis	2.19e-05	0.00026	CcSEcCtD
Doxorubicin—Anaemia—Prednisone—multiple sclerosis	2.18e-05	0.00026	CcSEcCtD
Doxorubicin—Shock—Dexamethasone—multiple sclerosis	2.18e-05	0.00026	CcSEcCtD
Doxorubicin—Shock—Betamethasone—multiple sclerosis	2.18e-05	0.00026	CcSEcCtD
Doxorubicin—Dyspnoea—Triamcinolone—multiple sclerosis	2.18e-05	0.000259	CcSEcCtD
Doxorubicin—Nervous system disorder—Betamethasone—multiple sclerosis	2.17e-05	0.000259	CcSEcCtD
Doxorubicin—Nervous system disorder—Dexamethasone—multiple sclerosis	2.17e-05	0.000259	CcSEcCtD
Doxorubicin—Agitation—Prednisone—multiple sclerosis	2.17e-05	0.000259	CcSEcCtD
Doxorubicin—Thrombocytopenia—Betamethasone—multiple sclerosis	2.17e-05	0.000258	CcSEcCtD
Doxorubicin—Thrombocytopenia—Dexamethasone—multiple sclerosis	2.17e-05	0.000258	CcSEcCtD
Doxorubicin—Tachycardia—Dexamethasone—multiple sclerosis	2.16e-05	0.000257	CcSEcCtD
Doxorubicin—Tachycardia—Betamethasone—multiple sclerosis	2.16e-05	0.000257	CcSEcCtD
Doxorubicin—Dyspepsia—Triamcinolone—multiple sclerosis	2.15e-05	0.000256	CcSEcCtD
Doxorubicin—Erythema multiforme—Methotrexate—multiple sclerosis	2.14e-05	0.000255	CcSEcCtD
Doxorubicin—Dyspepsia—Methylprednisolone—multiple sclerosis	2.14e-05	0.000255	CcSEcCtD
Doxorubicin—Hyperhidrosis—Betamethasone—multiple sclerosis	2.14e-05	0.000255	CcSEcCtD
Doxorubicin—Hyperhidrosis—Dexamethasone—multiple sclerosis	2.14e-05	0.000255	CcSEcCtD
Doxorubicin—Malaise—Prednisone—multiple sclerosis	2.13e-05	0.000254	CcSEcCtD
Doxorubicin—Vertigo—Prednisone—multiple sclerosis	2.12e-05	0.000253	CcSEcCtD
Doxorubicin—Eye disorder—Methotrexate—multiple sclerosis	2.12e-05	0.000253	CcSEcCtD
Doxorubicin—Syncope—Prednisone—multiple sclerosis	2.12e-05	0.000252	CcSEcCtD
Doxorubicin—Tinnitus—Methotrexate—multiple sclerosis	2.11e-05	0.000252	CcSEcCtD
Doxorubicin—Anorexia—Dexamethasone—multiple sclerosis	2.11e-05	0.000251	CcSEcCtD
Doxorubicin—Anorexia—Betamethasone—multiple sclerosis	2.11e-05	0.000251	CcSEcCtD
Doxorubicin—Urticaria—Prednisolone—multiple sclerosis	2.11e-05	0.000251	CcSEcCtD
Doxorubicin—Cardiac disorder—Methotrexate—multiple sclerosis	2.1e-05	0.000251	CcSEcCtD
Doxorubicin—Fatigue—Triamcinolone—multiple sclerosis	2.1e-05	0.000251	CcSEcCtD
Doxorubicin—Fatigue—Methylprednisolone—multiple sclerosis	2.1e-05	0.00025	CcSEcCtD
Doxorubicin—Pain—Triamcinolone—multiple sclerosis	2.09e-05	0.000249	CcSEcCtD
Doxorubicin—Loss of consciousness—Prednisone—multiple sclerosis	2.08e-05	0.000247	CcSEcCtD
Doxorubicin—Hypotension—Betamethasone—multiple sclerosis	2.07e-05	0.000246	CcSEcCtD
Doxorubicin—Hypotension—Dexamethasone—multiple sclerosis	2.07e-05	0.000246	CcSEcCtD
Doxorubicin—Angiopathy—Methotrexate—multiple sclerosis	2.06e-05	0.000245	CcSEcCtD
Doxorubicin—Vomiting—Mitoxantrone—multiple sclerosis	2.06e-05	0.000245	CcSEcCtD
Doxorubicin—Immune system disorder—Methotrexate—multiple sclerosis	2.05e-05	0.000244	CcSEcCtD
Doxorubicin—Convulsion—Prednisone—multiple sclerosis	2.05e-05	0.000244	CcSEcCtD
Doxorubicin—Mediastinal disorder—Methotrexate—multiple sclerosis	2.04e-05	0.000244	CcSEcCtD
Doxorubicin—Hypertension—Prednisone—multiple sclerosis	2.04e-05	0.000243	CcSEcCtD
Doxorubicin—Rash—Mitoxantrone—multiple sclerosis	2.04e-05	0.000243	CcSEcCtD
Doxorubicin—Dermatitis—Mitoxantrone—multiple sclerosis	2.04e-05	0.000243	CcSEcCtD
Doxorubicin—Chills—Methotrexate—multiple sclerosis	2.04e-05	0.000242	CcSEcCtD
Doxorubicin—Headache—Mitoxantrone—multiple sclerosis	2.03e-05	0.000241	CcSEcCtD
Doxorubicin—TOP2A—Azacitidine—Cladribine—multiple sclerosis	2.03e-05	0.0111	CbGdCrCtD
Doxorubicin—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	2.02e-05	0.00024	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	2.02e-05	0.00024	CcSEcCtD
Doxorubicin—Arthralgia—Prednisone—multiple sclerosis	2.01e-05	0.00024	CcSEcCtD
Doxorubicin—Myalgia—Prednisone—multiple sclerosis	2.01e-05	0.00024	CcSEcCtD
Doxorubicin—Feeling abnormal—Triamcinolone—multiple sclerosis	2.01e-05	0.00024	CcSEcCtD
Doxorubicin—Feeling abnormal—Methylprednisolone—multiple sclerosis	2.01e-05	0.000239	CcSEcCtD
Doxorubicin—Anxiety—Prednisone—multiple sclerosis	2e-05	0.000239	CcSEcCtD
Doxorubicin—Alopecia—Methotrexate—multiple sclerosis	2e-05	0.000239	CcSEcCtD
Doxorubicin—Insomnia—Dexamethasone—multiple sclerosis	2e-05	0.000239	CcSEcCtD
Doxorubicin—Insomnia—Betamethasone—multiple sclerosis	2e-05	0.000239	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	2e-05	0.000238	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	1.99e-05	0.000237	CcSEcCtD
Doxorubicin—Paraesthesia—Dexamethasone—multiple sclerosis	1.99e-05	0.000237	CcSEcCtD
Doxorubicin—Paraesthesia—Betamethasone—multiple sclerosis	1.99e-05	0.000237	CcSEcCtD
Doxorubicin—Discomfort—Prednisone—multiple sclerosis	1.99e-05	0.000237	CcSEcCtD
Doxorubicin—Mental disorder—Methotrexate—multiple sclerosis	1.99e-05	0.000237	CcSEcCtD
Doxorubicin—Malnutrition—Methotrexate—multiple sclerosis	1.97e-05	0.000235	CcSEcCtD
Doxorubicin—Erythema—Methotrexate—multiple sclerosis	1.97e-05	0.000235	CcSEcCtD
Doxorubicin—Hypersensitivity—Prednisolone—multiple sclerosis	1.95e-05	0.000233	CcSEcCtD
Doxorubicin—Dyspepsia—Betamethasone—multiple sclerosis	1.95e-05	0.000232	CcSEcCtD
Doxorubicin—Dyspepsia—Dexamethasone—multiple sclerosis	1.95e-05	0.000232	CcSEcCtD
Doxorubicin—Urticaria—Triamcinolone—multiple sclerosis	1.94e-05	0.000231	CcSEcCtD
Doxorubicin—Urticaria—Methylprednisolone—multiple sclerosis	1.93e-05	0.00023	CcSEcCtD
Doxorubicin—Dysgeusia—Methotrexate—multiple sclerosis	1.93e-05	0.00023	CcSEcCtD
Doxorubicin—Body temperature increased—Triamcinolone—multiple sclerosis	1.93e-05	0.00023	CcSEcCtD
Doxorubicin—Oedema—Prednisone—multiple sclerosis	1.93e-05	0.00023	CcSEcCtD
Doxorubicin—Anaphylactic shock—Prednisone—multiple sclerosis	1.93e-05	0.00023	CcSEcCtD
Doxorubicin—Abdominal pain—Methylprednisolone—multiple sclerosis	1.92e-05	0.000229	CcSEcCtD
Doxorubicin—Decreased appetite—Dexamethasone—multiple sclerosis	1.92e-05	0.000229	CcSEcCtD
Doxorubicin—Decreased appetite—Betamethasone—multiple sclerosis	1.92e-05	0.000229	CcSEcCtD
Doxorubicin—Nausea—Mitoxantrone—multiple sclerosis	1.92e-05	0.000229	CcSEcCtD
Doxorubicin—Infection—Prednisone—multiple sclerosis	1.92e-05	0.000228	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Betamethasone—multiple sclerosis	1.91e-05	0.000228	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	1.91e-05	0.000228	CcSEcCtD
Doxorubicin—Back pain—Methotrexate—multiple sclerosis	1.91e-05	0.000228	CcSEcCtD
Doxorubicin—Fatigue—Betamethasone—multiple sclerosis	1.91e-05	0.000227	CcSEcCtD
Doxorubicin—Fatigue—Dexamethasone—multiple sclerosis	1.91e-05	0.000227	CcSEcCtD
Doxorubicin—Shock—Prednisone—multiple sclerosis	1.9e-05	0.000226	CcSEcCtD
Doxorubicin—Pain—Dexamethasone—multiple sclerosis	1.89e-05	0.000226	CcSEcCtD
Doxorubicin—Pain—Betamethasone—multiple sclerosis	1.89e-05	0.000226	CcSEcCtD
Doxorubicin—Nervous system disorder—Prednisone—multiple sclerosis	1.89e-05	0.000225	CcSEcCtD
Doxorubicin—Tachycardia—Prednisone—multiple sclerosis	1.88e-05	0.000224	CcSEcCtD
Doxorubicin—Skin disorder—Prednisone—multiple sclerosis	1.87e-05	0.000223	CcSEcCtD
Doxorubicin—Hyperhidrosis—Prednisone—multiple sclerosis	1.86e-05	0.000222	CcSEcCtD
Doxorubicin—Vision blurred—Methotrexate—multiple sclerosis	1.86e-05	0.000222	CcSEcCtD
Doxorubicin—Anorexia—Prednisone—multiple sclerosis	1.84e-05	0.000219	CcSEcCtD
Doxorubicin—Ill-defined disorder—Methotrexate—multiple sclerosis	1.83e-05	0.000218	CcSEcCtD
Doxorubicin—Anaemia—Methotrexate—multiple sclerosis	1.82e-05	0.000217	CcSEcCtD
Doxorubicin—Feeling abnormal—Betamethasone—multiple sclerosis	1.82e-05	0.000217	CcSEcCtD
Doxorubicin—Feeling abnormal—Dexamethasone—multiple sclerosis	1.82e-05	0.000217	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Betamethasone—multiple sclerosis	1.81e-05	0.000216	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Dexamethasone—multiple sclerosis	1.81e-05	0.000216	CcSEcCtD
Doxorubicin—Hypersensitivity—Triamcinolone—multiple sclerosis	1.8e-05	0.000214	CcSEcCtD
Doxorubicin—Hypersensitivity—Methylprednisolone—multiple sclerosis	1.79e-05	0.000214	CcSEcCtD
Doxorubicin—Malaise—Methotrexate—multiple sclerosis	1.78e-05	0.000212	CcSEcCtD
Doxorubicin—Vertigo—Methotrexate—multiple sclerosis	1.77e-05	0.000211	CcSEcCtD
Doxorubicin—Leukopenia—Methotrexate—multiple sclerosis	1.77e-05	0.000211	CcSEcCtD
Doxorubicin—Urticaria—Dexamethasone—multiple sclerosis	1.76e-05	0.00021	CcSEcCtD
Doxorubicin—Urticaria—Betamethasone—multiple sclerosis	1.76e-05	0.00021	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Prednisone—multiple sclerosis	1.76e-05	0.000209	CcSEcCtD
Doxorubicin—Dizziness—Prednisolone—multiple sclerosis	1.75e-05	0.000209	CcSEcCtD
Doxorubicin—Asthenia—Triamcinolone—multiple sclerosis	1.75e-05	0.000209	CcSEcCtD
Doxorubicin—Abdominal pain—Betamethasone—multiple sclerosis	1.75e-05	0.000209	CcSEcCtD
Doxorubicin—Body temperature increased—Dexamethasone—multiple sclerosis	1.75e-05	0.000209	CcSEcCtD
Doxorubicin—Abdominal pain—Dexamethasone—multiple sclerosis	1.75e-05	0.000209	CcSEcCtD
Doxorubicin—Body temperature increased—Betamethasone—multiple sclerosis	1.75e-05	0.000209	CcSEcCtD
Doxorubicin—Asthenia—Methylprednisolone—multiple sclerosis	1.75e-05	0.000208	CcSEcCtD
Doxorubicin—Insomnia—Prednisone—multiple sclerosis	1.74e-05	0.000208	CcSEcCtD
Doxorubicin—Paraesthesia—Prednisone—multiple sclerosis	1.73e-05	0.000206	CcSEcCtD
Doxorubicin—Pruritus—Triamcinolone—multiple sclerosis	1.73e-05	0.000206	CcSEcCtD
Doxorubicin—Cough—Methotrexate—multiple sclerosis	1.72e-05	0.000205	CcSEcCtD
Doxorubicin—Pruritus—Methylprednisolone—multiple sclerosis	1.72e-05	0.000205	CcSEcCtD
Doxorubicin—Convulsion—Methotrexate—multiple sclerosis	1.71e-05	0.000204	CcSEcCtD
Doxorubicin—Dyspepsia—Prednisone—multiple sclerosis	1.7e-05	0.000202	CcSEcCtD
Doxorubicin—Myalgia—Methotrexate—multiple sclerosis	1.68e-05	0.0002	CcSEcCtD
Doxorubicin—Arthralgia—Methotrexate—multiple sclerosis	1.68e-05	0.0002	CcSEcCtD
Doxorubicin—Chest pain—Methotrexate—multiple sclerosis	1.68e-05	0.0002	CcSEcCtD
Doxorubicin—Decreased appetite—Prednisone—multiple sclerosis	1.68e-05	0.0002	CcSEcCtD
Doxorubicin—Rash—Prednisolone—multiple sclerosis	1.67e-05	0.000199	CcSEcCtD
Doxorubicin—Dermatitis—Prednisolone—multiple sclerosis	1.67e-05	0.000199	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	1.67e-05	0.000199	CcSEcCtD
Doxorubicin—Diarrhoea—Methylprednisolone—multiple sclerosis	1.67e-05	0.000198	CcSEcCtD
Doxorubicin—Fatigue—Prednisone—multiple sclerosis	1.66e-05	0.000198	CcSEcCtD
Doxorubicin—Headache—Prednisolone—multiple sclerosis	1.66e-05	0.000198	CcSEcCtD
Doxorubicin—Discomfort—Methotrexate—multiple sclerosis	1.66e-05	0.000198	CcSEcCtD
Doxorubicin—Constipation—Prednisone—multiple sclerosis	1.65e-05	0.000196	CcSEcCtD
Doxorubicin—Confusional state—Methotrexate—multiple sclerosis	1.62e-05	0.000194	CcSEcCtD
Doxorubicin—Dizziness—Triamcinolone—multiple sclerosis	1.61e-05	0.000192	CcSEcCtD
Doxorubicin—Anaphylactic shock—Methotrexate—multiple sclerosis	1.61e-05	0.000192	CcSEcCtD
Doxorubicin—Dizziness—Methylprednisolone—multiple sclerosis	1.61e-05	0.000192	CcSEcCtD
Doxorubicin—Infection—Methotrexate—multiple sclerosis	1.6e-05	0.000191	CcSEcCtD
Doxorubicin—Feeling abnormal—Prednisone—multiple sclerosis	1.59e-05	0.000189	CcSEcCtD
Doxorubicin—Asthenia—Betamethasone—multiple sclerosis	1.59e-05	0.000189	CcSEcCtD
Doxorubicin—Asthenia—Dexamethasone—multiple sclerosis	1.59e-05	0.000189	CcSEcCtD
Doxorubicin—Nervous system disorder—Methotrexate—multiple sclerosis	1.58e-05	0.000188	CcSEcCtD
Doxorubicin—Thrombocytopenia—Methotrexate—multiple sclerosis	1.58e-05	0.000188	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Prednisone—multiple sclerosis	1.58e-05	0.000188	CcSEcCtD
Doxorubicin—Nausea—Prednisolone—multiple sclerosis	1.58e-05	0.000188	CcSEcCtD
Doxorubicin—Pruritus—Dexamethasone—multiple sclerosis	1.57e-05	0.000187	CcSEcCtD
Doxorubicin—Pruritus—Betamethasone—multiple sclerosis	1.57e-05	0.000187	CcSEcCtD
Doxorubicin—Skin disorder—Methotrexate—multiple sclerosis	1.57e-05	0.000186	CcSEcCtD
Doxorubicin—Hyperhidrosis—Methotrexate—multiple sclerosis	1.56e-05	0.000186	CcSEcCtD
Doxorubicin—Vomiting—Triamcinolone—multiple sclerosis	1.55e-05	0.000185	CcSEcCtD
Doxorubicin—Vomiting—Methylprednisolone—multiple sclerosis	1.55e-05	0.000184	CcSEcCtD
Doxorubicin—Rash—Triamcinolone—multiple sclerosis	1.54e-05	0.000183	CcSEcCtD
Doxorubicin—Dermatitis—Triamcinolone—multiple sclerosis	1.54e-05	0.000183	CcSEcCtD
Doxorubicin—Anorexia—Methotrexate—multiple sclerosis	1.54e-05	0.000183	CcSEcCtD
Doxorubicin—Rash—Methylprednisolone—multiple sclerosis	1.54e-05	0.000183	CcSEcCtD
Doxorubicin—Dermatitis—Methylprednisolone—multiple sclerosis	1.53e-05	0.000183	CcSEcCtD
Doxorubicin—Urticaria—Prednisone—multiple sclerosis	1.53e-05	0.000182	CcSEcCtD
Doxorubicin—Headache—Triamcinolone—multiple sclerosis	1.53e-05	0.000182	CcSEcCtD
Doxorubicin—Headache—Methylprednisolone—multiple sclerosis	1.53e-05	0.000182	CcSEcCtD
Doxorubicin—Abdominal pain—Prednisone—multiple sclerosis	1.52e-05	0.000182	CcSEcCtD
Doxorubicin—Body temperature increased—Prednisone—multiple sclerosis	1.52e-05	0.000182	CcSEcCtD
Doxorubicin—Diarrhoea—Betamethasone—multiple sclerosis	1.51e-05	0.00018	CcSEcCtD
Doxorubicin—Diarrhoea—Dexamethasone—multiple sclerosis	1.51e-05	0.00018	CcSEcCtD
Doxorubicin—Hypotension—Methotrexate—multiple sclerosis	1.51e-05	0.000179	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	1.47e-05	0.000175	CcSEcCtD
Doxorubicin—Dizziness—Betamethasone—multiple sclerosis	1.46e-05	0.000174	CcSEcCtD
Doxorubicin—Dizziness—Dexamethasone—multiple sclerosis	1.46e-05	0.000174	CcSEcCtD
Doxorubicin—Insomnia—Methotrexate—multiple sclerosis	1.46e-05	0.000174	CcSEcCtD
Doxorubicin—Nausea—Triamcinolone—multiple sclerosis	1.45e-05	0.000173	CcSEcCtD
Doxorubicin—Paraesthesia—Methotrexate—multiple sclerosis	1.45e-05	0.000172	CcSEcCtD
Doxorubicin—Nausea—Methylprednisolone—multiple sclerosis	1.45e-05	0.000172	CcSEcCtD
Doxorubicin—Dyspnoea—Methotrexate—multiple sclerosis	1.44e-05	0.000171	CcSEcCtD
Doxorubicin—Somnolence—Methotrexate—multiple sclerosis	1.43e-05	0.000171	CcSEcCtD
Doxorubicin—Hypersensitivity—Prednisone—multiple sclerosis	1.42e-05	0.000169	CcSEcCtD
Doxorubicin—Dyspepsia—Methotrexate—multiple sclerosis	1.42e-05	0.000169	CcSEcCtD
Doxorubicin—Vomiting—Dexamethasone—multiple sclerosis	1.41e-05	0.000168	CcSEcCtD
Doxorubicin—Vomiting—Betamethasone—multiple sclerosis	1.41e-05	0.000168	CcSEcCtD
Doxorubicin—Decreased appetite—Methotrexate—multiple sclerosis	1.4e-05	0.000167	CcSEcCtD
Doxorubicin—Rash—Betamethasone—multiple sclerosis	1.4e-05	0.000166	CcSEcCtD
Doxorubicin—Rash—Dexamethasone—multiple sclerosis	1.4e-05	0.000166	CcSEcCtD
Doxorubicin—Dermatitis—Betamethasone—multiple sclerosis	1.39e-05	0.000166	CcSEcCtD
Doxorubicin—Dermatitis—Dexamethasone—multiple sclerosis	1.39e-05	0.000166	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Methotrexate—multiple sclerosis	1.39e-05	0.000166	CcSEcCtD
Doxorubicin—Fatigue—Methotrexate—multiple sclerosis	1.39e-05	0.000166	CcSEcCtD
Doxorubicin—Headache—Dexamethasone—multiple sclerosis	1.39e-05	0.000165	CcSEcCtD
Doxorubicin—Headache—Betamethasone—multiple sclerosis	1.39e-05	0.000165	CcSEcCtD
Doxorubicin—Asthenia—Prednisone—multiple sclerosis	1.38e-05	0.000165	CcSEcCtD
Doxorubicin—Pain—Methotrexate—multiple sclerosis	1.38e-05	0.000164	CcSEcCtD
Doxorubicin—Pruritus—Prednisone—multiple sclerosis	1.36e-05	0.000163	CcSEcCtD
Doxorubicin—Feeling abnormal—Methotrexate—multiple sclerosis	1.33e-05	0.000158	CcSEcCtD
Doxorubicin—Diarrhoea—Prednisone—multiple sclerosis	1.32e-05	0.000157	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Methotrexate—multiple sclerosis	1.32e-05	0.000157	CcSEcCtD
Doxorubicin—Nausea—Betamethasone—multiple sclerosis	1.32e-05	0.000157	CcSEcCtD
Doxorubicin—Nausea—Dexamethasone—multiple sclerosis	1.32e-05	0.000157	CcSEcCtD
Doxorubicin—Urticaria—Methotrexate—multiple sclerosis	1.28e-05	0.000153	CcSEcCtD
Doxorubicin—Dizziness—Prednisone—multiple sclerosis	1.28e-05	0.000152	CcSEcCtD
Doxorubicin—Body temperature increased—Methotrexate—multiple sclerosis	1.27e-05	0.000152	CcSEcCtD
Doxorubicin—Abdominal pain—Methotrexate—multiple sclerosis	1.27e-05	0.000152	CcSEcCtD
Doxorubicin—TOP2A—Methyltestosterone—Prednisone—multiple sclerosis	1.24e-05	0.00679	CbGdCrCtD
Doxorubicin—Vomiting—Prednisone—multiple sclerosis	1.23e-05	0.000146	CcSEcCtD
Doxorubicin—Rash—Prednisone—multiple sclerosis	1.22e-05	0.000145	CcSEcCtD
Doxorubicin—Dermatitis—Prednisone—multiple sclerosis	1.21e-05	0.000145	CcSEcCtD
Doxorubicin—TOP2A—Methyltestosterone—Prednisolone—multiple sclerosis	1.21e-05	0.00663	CbGdCrCtD
Doxorubicin—Headache—Prednisone—multiple sclerosis	1.21e-05	0.000144	CcSEcCtD
Doxorubicin—Hypersensitivity—Methotrexate—multiple sclerosis	1.19e-05	0.000141	CcSEcCtD
Doxorubicin—Asthenia—Methotrexate—multiple sclerosis	1.16e-05	0.000138	CcSEcCtD
Doxorubicin—Nausea—Prednisone—multiple sclerosis	1.15e-05	0.000136	CcSEcCtD
Doxorubicin—Pruritus—Methotrexate—multiple sclerosis	1.14e-05	0.000136	CcSEcCtD
Doxorubicin—Diarrhoea—Methotrexate—multiple sclerosis	1.1e-05	0.000131	CcSEcCtD
Doxorubicin—Dizziness—Methotrexate—multiple sclerosis	1.07e-05	0.000127	CcSEcCtD
Doxorubicin—Vomiting—Methotrexate—multiple sclerosis	1.02e-05	0.000122	CcSEcCtD
Doxorubicin—Rash—Methotrexate—multiple sclerosis	1.02e-05	0.000121	CcSEcCtD
Doxorubicin—Dermatitis—Methotrexate—multiple sclerosis	1.02e-05	0.000121	CcSEcCtD
Doxorubicin—Headache—Methotrexate—multiple sclerosis	1.01e-05	0.00012	CcSEcCtD
Doxorubicin—Nausea—Methotrexate—multiple sclerosis	9.57e-06	0.000114	CcSEcCtD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	8.8e-06	0.000196	CbGpPWpGaD
Doxorubicin—CYP2B6—Biological oxidations—POMC—multiple sclerosis	8.76e-06	0.000195	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—BCHE—multiple sclerosis	8.73e-06	0.000195	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CCR5—multiple sclerosis	8.71e-06	0.000194	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—POMC—multiple sclerosis	8.58e-06	0.000192	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—IL2RA—multiple sclerosis	8.58e-06	0.000191	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—ALB—multiple sclerosis	8.57e-06	0.000191	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	8.55e-06	0.000191	CbGpPWpGaD
Doxorubicin—AURKA—Cell Cycle—MYC—multiple sclerosis	8.51e-06	0.00019	CbGpPWpGaD
Doxorubicin—NOS2—Disease—CD86—multiple sclerosis	8.45e-06	0.000189	CbGpPWpGaD
Doxorubicin—AURKA—Cell Cycle—MAPK1—multiple sclerosis	8.33e-06	0.000186	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—GPC5—multiple sclerosis	8.31e-06	0.000185	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CCL3—multiple sclerosis	8.28e-06	0.000185	CbGpPWpGaD
Doxorubicin—NOS1—Disease—CD80—multiple sclerosis	8.18e-06	0.000182	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—BCHE—multiple sclerosis	8.11e-06	0.000181	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.08e-06	0.00018	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—POMC—multiple sclerosis	8.01e-06	0.000179	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—PTGER4—multiple sclerosis	7.97e-06	0.000178	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—APOE—multiple sclerosis	7.92e-06	0.000177	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—PGR—multiple sclerosis	7.85e-06	0.000175	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—ALB—multiple sclerosis	7.83e-06	0.000175	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—RRM1—multiple sclerosis	7.82e-06	0.000175	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—CD86—multiple sclerosis	7.77e-06	0.000173	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	7.74e-06	0.000173	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CXCR3—multiple sclerosis	7.7e-06	0.000172	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CD28—multiple sclerosis	7.62e-06	0.00017	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—RRM1—multiple sclerosis	7.56e-06	0.000169	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	7.53e-06	0.000168	CbGpPWpGaD
Doxorubicin—TOP2A—Circadian rythm related genes—IL6—multiple sclerosis	7.52e-06	0.000168	CbGpPWpGaD
Doxorubicin—NOS2—Disease—CCR5—multiple sclerosis	7.5e-06	0.000167	CbGpPWpGaD
Doxorubicin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.49e-06	0.000167	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CCR2—multiple sclerosis	7.49e-06	0.000167	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—BCHE—multiple sclerosis	7.37e-06	0.000165	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—RPL5—multiple sclerosis	7.33e-06	0.000164	CbGpPWpGaD
Doxorubicin—NOS2—Disease—HLA-A—multiple sclerosis	7.31e-06	0.000163	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—ALB—multiple sclerosis	7.3e-06	0.000163	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle, Mitotic—MYC—multiple sclerosis	7.22e-06	0.000161	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CD80—multiple sclerosis	7.16e-06	0.00016	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle, Mitotic—MAPK1—multiple sclerosis	7.06e-06	0.000158	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—SLC11A1—multiple sclerosis	7.02e-06	0.000157	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CCL3—multiple sclerosis	6.99e-06	0.000156	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—TGFB1—multiple sclerosis	6.98e-06	0.000156	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—SRM—multiple sclerosis	6.97e-06	0.000156	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—IL2—multiple sclerosis	6.95e-06	0.000155	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	6.94e-06	0.000155	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.94e-06	0.000155	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CNR1—multiple sclerosis	6.91e-06	0.000154	CbGpPWpGaD
Doxorubicin—NOS1—Disease—TYK2—multiple sclerosis	6.9e-06	0.000154	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—CCR5—multiple sclerosis	6.89e-06	0.000154	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—RRM1—multiple sclerosis	6.88e-06	0.000154	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—MAPK1—multiple sclerosis	6.84e-06	0.000153	CbGpPWpGaD
Doxorubicin—NOS2—Disease—APOE—multiple sclerosis	6.82e-06	0.000152	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—POMC—multiple sclerosis	6.8e-06	0.000152	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	6.76e-06	0.000151	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PTGER4—multiple sclerosis	6.73e-06	0.00015	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—HLA-A—multiple sclerosis	6.71e-06	0.00015	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CCL2—multiple sclerosis	6.66e-06	0.000149	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	6.66e-06	0.000149	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	6.66e-06	0.000149	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.65e-06	0.000148	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PGR—multiple sclerosis	6.63e-06	0.000148	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—SRM—multiple sclerosis	6.57e-06	0.000147	CbGpPWpGaD
Doxorubicin—NOS3—Disease—CD86—multiple sclerosis	6.56e-06	0.000146	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CXCR3—multiple sclerosis	6.5e-06	0.000145	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—TNF—multiple sclerosis	6.48e-06	0.000145	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—MYC—multiple sclerosis	6.45e-06	0.000144	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CD28—multiple sclerosis	6.44e-06	0.000144	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.33e-06	0.000141	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CCR2—multiple sclerosis	6.33e-06	0.000141	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—MAPK1—multiple sclerosis	6.31e-06	0.000141	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—APOE—multiple sclerosis	6.27e-06	0.00014	CbGpPWpGaD
Doxorubicin—NOS1—Disease—CD4—multiple sclerosis	6.24e-06	0.000139	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CXCL10—multiple sclerosis	6.22e-06	0.000139	CbGpPWpGaD
Doxorubicin—NOS2—Disease—CD80—multiple sclerosis	6.17e-06	0.000138	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GPC5—multiple sclerosis	6.09e-06	0.000136	CbGpPWpGaD
Doxorubicin—CYP2D6—Biological oxidations—POMC—multiple sclerosis	6.09e-06	0.000136	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	6.07e-06	0.000135	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.07e-06	0.000135	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TYK2—multiple sclerosis	6.05e-06	0.000135	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—BCHE—multiple sclerosis	5.98e-06	0.000133	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	5.97e-06	0.000133	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	5.87e-06	0.000131	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CNR1—multiple sclerosis	5.84e-06	0.00013	CbGpPWpGaD
Doxorubicin—NOS3—Disease—CCR5—multiple sclerosis	5.82e-06	0.00013	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.77e-06	0.000129	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—BCHE—multiple sclerosis	5.73e-06	0.000128	CbGpPWpGaD
Doxorubicin—NOS3—Disease—HLA-A—multiple sclerosis	5.67e-06	0.000127	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—CD80—multiple sclerosis	5.67e-06	0.000126	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CD28—multiple sclerosis	5.61e-06	0.000125	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—APOE—multiple sclerosis	5.44e-06	0.000121	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CD86—multiple sclerosis	5.44e-06	0.000121	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—TGFB1—multiple sclerosis	5.42e-06	0.000121	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CCL5—multiple sclerosis	5.35e-06	0.000119	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—MAPK1—multiple sclerosis	5.31e-06	0.000119	CbGpPWpGaD
Doxorubicin—NOS3—Disease—APOE—multiple sclerosis	5.3e-06	0.000118	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CXCL10—multiple sclerosis	5.26e-06	0.000117	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—APOE—multiple sclerosis	5.25e-06	0.000117	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	5.21e-06	0.000116	CbGpPWpGaD
Doxorubicin—NOS2—Disease—TYK2—multiple sclerosis	5.21e-06	0.000116	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle, Mitotic—MYC—multiple sclerosis	5.05e-06	0.000113	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—RRM1—multiple sclerosis	5.05e-06	0.000113	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	5.04e-06	0.000113	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—IL2—multiple sclerosis	5.03e-06	0.000112	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—SPP1—multiple sclerosis	4.96e-06	0.000111	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle, Mitotic—MAPK1—multiple sclerosis	4.94e-06	0.00011	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CYP27B1—multiple sclerosis	4.91e-06	0.00011	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CYP24A1—multiple sclerosis	4.91e-06	0.00011	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—APOE—multiple sclerosis	4.88e-06	0.000109	CbGpPWpGaD
Doxorubicin—NOS1—Disease—STAT3—multiple sclerosis	4.83e-06	0.000108	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CCR5—multiple sclerosis	4.82e-06	0.000108	CbGpPWpGaD
Doxorubicin—NOS3—Disease—CD80—multiple sclerosis	4.79e-06	0.000107	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—TYK2—multiple sclerosis	4.78e-06	0.000107	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—MMP9—multiple sclerosis	4.76e-06	0.000106	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IL2RA—multiple sclerosis	4.75e-06	0.000106	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.75e-06	0.000106	CbGpPWpGaD
Doxorubicin—NOS2—Disease—CD4—multiple sclerosis	4.71e-06	0.000105	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—POMC—multiple sclerosis	4.67e-06	0.000104	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	4.63e-06	0.000103	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	4.63e-06	0.000103	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.6e-06	0.000103	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CD86—multiple sclerosis	4.6e-06	0.000103	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—ALB—multiple sclerosis	4.57e-06	0.000102	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CCL5—multiple sclerosis	4.52e-06	0.000101	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—ALB—multiple sclerosis	4.52e-06	0.000101	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—MYC—multiple sclerosis	4.51e-06	0.000101	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—POMC—multiple sclerosis	4.51e-06	0.000101	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—BCHE—multiple sclerosis	4.49e-06	0.0001	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GPC5—multiple sclerosis	4.49e-06	0.0001	CbGpPWpGaD
Doxorubicin—NOS1—Disease—MYC—multiple sclerosis	4.49e-06	0.0001	CbGpPWpGaD
Doxorubicin—NOS1—Disease—TGFB1—multiple sclerosis	4.48e-06	0.0001	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—APOE—multiple sclerosis	4.44e-06	9.9e-05	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—MAPK1—multiple sclerosis	4.42e-06	9.85e-05	CbGpPWpGaD
Doxorubicin—NOS1—Disease—MAPK1—multiple sclerosis	4.39e-06	9.8e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—APOE—multiple sclerosis	4.39e-06	9.79e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—BCHE—multiple sclerosis	4.34e-06	9.7e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—CD4—multiple sclerosis	4.33e-06	9.65e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—SRM—multiple sclerosis	4.29e-06	9.58e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—ALB—multiple sclerosis	4.26e-06	9.51e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—STAT3—multiple sclerosis	4.23e-06	9.45e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GPC5—multiple sclerosis	4.23e-06	9.44e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—POMC—multiple sclerosis	4.19e-06	9.35e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—SPP1—multiple sclerosis	4.19e-06	9.35e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—ALB—multiple sclerosis	4.11e-06	9.17e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CCR5—multiple sclerosis	4.08e-06	9.1e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—TYK2—multiple sclerosis	4.04e-06	9.02e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IL2RA—multiple sclerosis	4.02e-06	8.96e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CD86—multiple sclerosis	4e-06	8.92e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Biological oxidations—POMC—multiple sclerosis	3.98e-06	8.88e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.98e-06	8.87e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CD80—multiple sclerosis	3.97e-06	8.86e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—BCHE—multiple sclerosis	3.95e-06	8.82e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—MYC—multiple sclerosis	3.93e-06	8.78e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TGFB1—multiple sclerosis	3.92e-06	8.76e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—MAPK1—multiple sclerosis	3.85e-06	8.59e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—ALB—multiple sclerosis	3.82e-06	8.53e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—POMC—multiple sclerosis	3.81e-06	8.5e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—POMC—multiple sclerosis	3.77e-06	8.41e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—RRM1—multiple sclerosis	3.72e-06	8.3e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—APOE—multiple sclerosis	3.71e-06	8.28e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CCL2—multiple sclerosis	3.69e-06	8.23e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—CD4—multiple sclerosis	3.66e-06	8.16e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—STAT3—multiple sclerosis	3.64e-06	8.13e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—APOE—multiple sclerosis	3.6e-06	8.03e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CCR5—multiple sclerosis	3.55e-06	7.92e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—RRM1—multiple sclerosis	3.51e-06	7.82e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—ALB—multiple sclerosis	3.47e-06	7.75e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—HLA-A—multiple sclerosis	3.46e-06	7.71e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—APOE—multiple sclerosis	3.45e-06	7.7e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	3.43e-06	7.66e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	3.42e-06	7.64e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—MYC—multiple sclerosis	3.39e-06	7.56e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—TGFB1—multiple sclerosis	3.38e-06	7.54e-05	CbGpPWpGaD
Doxorubicin—NOS1—Disease—IL6—multiple sclerosis	3.38e-06	7.53e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	3.36e-06	7.5e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CD80—multiple sclerosis	3.35e-06	7.48e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TYK2—multiple sclerosis	3.35e-06	7.48e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—STAT3—multiple sclerosis	3.35e-06	7.47e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—MAPK1—multiple sclerosis	3.31e-06	7.39e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—APOE—multiple sclerosis	3.23e-06	7.2e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	3.2e-06	7.14e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—POMC—multiple sclerosis	3.19e-06	7.11e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CCL2—multiple sclerosis	3.12e-06	6.96e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—MYC—multiple sclerosis	3.11e-06	6.95e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—TGFB1—multiple sclerosis	3.1e-06	6.93e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—POMC—multiple sclerosis	3.09e-06	6.9e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—MAPK1—multiple sclerosis	3.04e-06	6.79e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	3.03e-06	6.75e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	3.03e-06	6.75e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—POMC—multiple sclerosis	2.96e-06	6.61e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—IL6—multiple sclerosis	2.96e-06	6.6e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CD80—multiple sclerosis	2.92e-06	6.51e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—BCHE—multiple sclerosis	2.9e-06	6.47e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TYK2—multiple sclerosis	2.83e-06	6.32e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—STAT3—multiple sclerosis	2.83e-06	6.32e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—ALB—multiple sclerosis	2.82e-06	6.29e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IL2—multiple sclerosis	2.79e-06	6.22e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GPC5—multiple sclerosis	2.77e-06	6.17e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—APOE—multiple sclerosis	2.7e-06	6.03e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—ALB—multiple sclerosis	2.7e-06	6.03e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—MMP9—multiple sclerosis	2.64e-06	5.89e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—MYC—multiple sclerosis	2.63e-06	5.87e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—TGFB1—multiple sclerosis	2.62e-06	5.85e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—APOE—multiple sclerosis	2.61e-06	5.83e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—MAPK1—multiple sclerosis	2.57e-06	5.74e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—IL6—multiple sclerosis	2.55e-06	5.68e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—TYK2—multiple sclerosis	2.46e-06	5.5e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—APOE—multiple sclerosis	2.38e-06	5.31e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IL2—multiple sclerosis	2.36e-06	5.26e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—STAT3—multiple sclerosis	2.35e-06	5.23e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—IL6—multiple sclerosis	2.34e-06	5.22e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—POMC—multiple sclerosis	2.32e-06	5.18e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—RRM1—multiple sclerosis	2.29e-06	5.12e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—POMC—multiple sclerosis	2.25e-06	5.01e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MMP9—multiple sclerosis	2.23e-06	4.97e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CD4—multiple sclerosis	2.23e-06	4.97e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—MYC—multiple sclerosis	2.18e-06	4.86e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TGFB1—multiple sclerosis	2.17e-06	4.85e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.15e-06	4.8e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—BCHE—multiple sclerosis	2.14e-06	4.77e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—MAPK1—multiple sclerosis	2.13e-06	4.76e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—ALB—multiple sclerosis	2.12e-06	4.72e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—ALB—multiple sclerosis	2.05e-06	4.57e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—POMC—multiple sclerosis	2.04e-06	4.56e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—BCHE—multiple sclerosis	2.01e-06	4.49e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—STAT3—multiple sclerosis	1.98e-06	4.42e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—IL6—multiple sclerosis	1.98e-06	4.41e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—ALB—multiple sclerosis	1.86e-06	4.16e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MYC—multiple sclerosis	1.84e-06	4.11e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TGFB1—multiple sclerosis	1.84e-06	4.1e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MAPK1—multiple sclerosis	1.8e-06	4.02e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—APOE—multiple sclerosis	1.74e-06	3.89e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—STAT3—multiple sclerosis	1.72e-06	3.85e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IL6—multiple sclerosis	1.64e-06	3.66e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—MYC—multiple sclerosis	1.6e-06	3.58e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—TGFB1—multiple sclerosis	1.6e-06	3.57e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—MAPK1—multiple sclerosis	1.57e-06	3.5e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—POMC—multiple sclerosis	1.5e-06	3.34e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IL6—multiple sclerosis	1.38e-06	3.09e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ALB—multiple sclerosis	1.37e-06	3.05e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.32e-06	2.94e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—APOE—multiple sclerosis	1.29e-06	2.87e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—APOE—multiple sclerosis	1.21e-06	2.7e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—IL6—multiple sclerosis	1.2e-06	2.69e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—POMC—multiple sclerosis	1.1e-06	2.46e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—POMC—multiple sclerosis	1.04e-06	2.32e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ALB—multiple sclerosis	1.01e-06	2.25e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ALB—multiple sclerosis	9.49e-07	2.12e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—APOE—multiple sclerosis	7.92e-07	1.77e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—POMC—multiple sclerosis	6.8e-07	1.52e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ALB—multiple sclerosis	6.2e-07	1.38e-05	CbGpPWpGaD
